Status:
COMPLETED
Special Survey on PD Patients With Renal Dysfunction
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
20+ years
Brief Summary
The survey is conducted to collect safety and effectiveness information targeting patients who have both Parkinson's disease and renal dysfunction treated with Pramipexole in the daily clinical settin...
Eligibility Criteria
Inclusion
- Patients with Parkinson's disease who have renal dysfunction with pretreatment creatinine clearance =\<70mL/min or whose renal dysfunction was determined by the physician
Exclusion
- None
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00613756
Start Date
February 1 2004
Last Update
November 13 2013
Active Locations (98)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Asahikawa, Japan
2
Boehringer Ingelheim Investigational Site
Azumino, Japan
3
Boehringer Ingelheim Investigational Site
Chūō, Japan
4
Boehringer Ingelheim Investigational Site
Fuji, Japan